Phase 1 study of isatuximab monotherapy in Chinese patients with relapsed/refractory multiple myeloma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Phase 1 study of isatuximab monotherapy in Chinese patients with relapsed/refractory multiple myeloma ; volume:14 ; number:1 ; day:11 ; month:11 ; year:2024 ; pages:1-9 ; date:12.2024
Scientific reports ; 14, Heft 1 (11.11.2024), 1-9, 12.2024
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Sun, Mingyuan
Jing, Hongmei
Qu, Xiaoyan
Dong, Fei
Li, Yi
Feng, Zhaoyi
Ziti-Ljajic, Samira
Semiond, Dorothee
Li, Lingyu
Qi, Junyuan
Qiu, Lugui
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-59186-1
- URN
-
urn:nbn:de:101:1-2501282139206.476094213074
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sun, Mingyuan
- Jing, Hongmei
- Qu, Xiaoyan
- Dong, Fei
- Li, Yi
- Feng, Zhaoyi
- Ziti-Ljajic, Samira
- Semiond, Dorothee
- Li, Lingyu
- Qi, Junyuan
- Qiu, Lugui
- SpringerLink (Online service)
Ähnliche Objekte (12)
Regelung und Wirkungsgradmessung einer Netzeinspeisungsanlage zur Windenergienutzung
Hot stage separation of rockets using coupled CFD and flight mechanics method
Impact of Coarse-Mode Aerosol on Jiangxi Warm Clouds Considering Different Updraft and Activation Intensities: An SBM-FAST Approach
Current problems with the prerequisites for flipped classroom teaching---a case study in a university in Northwest China
Local curvature estimates for the Laplacian flow
Daratumumab Plus Carfilzomib: An Optimistic Approach in Relapsed/Refractory Multiple Myeloma
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Emerging agents and regimens for multiple myeloma
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
tRNA-derived fragments as novel potential biomarkers for relapsed/refractory multiple myeloma
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials
Intercultural competence development in higher education study abroad programs: a good practice example
Regelung und Wirkungsgradmessung einer Netzeinspeisungsanlage zur Windenergienutzung
Hot stage separation of rockets using coupled CFD and flight mechanics method
Impact of Coarse-Mode Aerosol on Jiangxi Warm Clouds Considering Different Updraft and Activation Intensities: An SBM-FAST Approach
Current problems with the prerequisites for flipped classroom teaching---a case study in a university in Northwest China
Local curvature estimates for the Laplacian flow
Daratumumab Plus Carfilzomib: An Optimistic Approach in Relapsed/Refractory Multiple Myeloma
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Emerging agents and regimens for multiple myeloma
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
tRNA-derived fragments as novel potential biomarkers for relapsed/refractory multiple myeloma
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials
Intercultural competence development in higher education study abroad programs: a good practice example
Regelung und Wirkungsgradmessung einer Netzeinspeisungsanlage zur Windenergienutzung
Hot stage separation of rockets using coupled CFD and flight mechanics method
Impact of Coarse-Mode Aerosol on Jiangxi Warm Clouds Considering Different Updraft and Activation Intensities: An SBM-FAST Approach
Current problems with the prerequisites for flipped classroom teaching---a case study in a university in Northwest China
Local curvature estimates for the Laplacian flow
Daratumumab Plus Carfilzomib: An Optimistic Approach in Relapsed/Refractory Multiple Myeloma
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Emerging agents and regimens for multiple myeloma
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
tRNA-derived fragments as novel potential biomarkers for relapsed/refractory multiple myeloma
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials